Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress

Journal of Neurochemistry

Volumn 121, Issue 6, 2012, Pages 985-995

  Fernández Gamba, Agata ^a   Leal, María Celeste ^a   Maarouf, Chera L ^b   Richter Landsberg, Christiane ^c   Wu, Terence ^d   Morelli, Laura ^a   Roher, Alex E ^b   Castaño, Eduardo M ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF OLDENBURG   (Germany)

^d YALE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Axonal myelination; CRMP 2; Oligodendrocyte; Oxidative stress; Rho kinase

Indexed keywords

3 NITROPROPIONIC ACID; ANTIOXIDANT; CELL SURFACE PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DCC PROTEIN; NETRIN 1; REACTIVE OXYGEN METABOLITE; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL LINE; CELL LYSATE; CONTROLLED STUDY; ENZYME INHIBITION; INTRACELLULAR SIGNALING; MITOCHONDRION; NONHUMAN; OLIGODENDROCYTE BRANCHING; OLIGODENDROCYTE RETRACTION; OLIGODENDROCYTE SHORTENING; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; OXIDATIVE STRESS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION;

EID: 84862016324     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07742.x     Document Type: Article

References (83)

1. Aghajanian A., Wittchen E. S., Campbell S. L. and Burridge K. (2009) Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS ONE 4, e8045.
2. Arimura N., Inagaki N., Chihara K., Menager C., Nakamura N., Amano M., Iwamatsu A., Goshima Y. and Kaibuchi K. (2000) Phosphorylation of collapsin response mediator protein-2 by Rhokinase Evidence for two separate signaling pathways for growth cone collapse. J. Biol. Chem. 275, 23973-23980. (Pubitemid 30624686)
3. Arimura N., Menager C., Kawano Y. et al. (2005) Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol. Cell. Biol. 25, 9973-9984. (Pubitemid 41572744)
4. Back S. A., Gan X., Li Y., Rosenberg P. A. and Volpe J. J. (1998) Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 18, 6241-6253. (Pubitemid 28373231)
5. Back S. A., Luo N. L., Borenstein N. S., Levine J. M., Volpe J. J. and Kinney H. C. (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J. Neurosci. 21, 1302-1312. (Pubitemid 32128775)
6. Bacon C., Lakics V., Machesky L. and Rumsby M. (2007) N-WASP regulates extension of filopodia and processes by oligodendrocyte progenitors, oligodendrocytes, and Schwann cells-implications for axon ensheathment at myelination. Glia 55, 844-858. (Pubitemid 46787195)
7. Bacsi A., Woodberry M., Widger W., Papaconstantinou J., Mitra S., Peterson J. W. and Boldogh I. (2006) Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells. Mitochondrion 6, 235-244. (Pubitemid 44567383)
8. Bartzokis G., Sultzer D., Lu P. H., Nuechterlein K. H., Mintz J. and Cummings J. L. (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 25, 843-851. (Pubitemid 38813164)
9. Baumann N. and Pham-Dinh D. (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871-927. (Pubitemid 32267079)
10. Benes F. M., Turtle M., Khan Y. and Farol P. (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry 51, 477-484. (Pubitemid 24180494)
11. Bouchard J. F., Moore S. W., Tritsch N. X., Roux P. P., Shekarabi M., Barker P. A. and Kennedy T. E. (2004) Protein kinase A activation promotes plasma membrane insertion of DCC from an intracellular pool: A novel mechanism regulating commissural axon extension. J. Neurosci. 24, 3040-3050. (Pubitemid 38405751)
12. Boudreau A. C., Ferrario C. R., Glucksman M. J. and Wolf M. E. (2009) Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine. J. Neurochem. 110, 363-377.
13. Braak H. and Braak E. (1996) Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92, 197-201. (Pubitemid 26248463)
14. Bretin S., Reibel S., Charrier E. et al. (2005) Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain. J. Comp. Neurol. 486, 1-17. (Pubitemid 40571646)
15. Castegna A., Aksenov M., Thongboonkerd V., Klein J. B., Pierce W. M., Booze R., Markesbery W. R. and Butterfield D. A. (2002) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J. Neurochem. 82, 1524-1532.
16. Chae Y. C., Lee S., Heo K., Ha S. H., Jung Y., Kim J. H., Ihara Y., Suh P. G. and Ryu S. H. (2009) Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity. Cell. Signal. 21, 1818-1826.
17. Chen A., Liao W. P., Lu Q., Wong W. S. and Wong P. T. (2007) Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats-a proteomics approach. Neurochem. Int. 50, 1078-1086. (Pubitemid 46962809)
18. Cole A. R., Knebel A., Morrice N. A., Robertson L. A., Irving A. J., Connolly C. N. and Sutherland C. (2004) GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J. Biol. Chem. 279, 50176-50180. (Pubitemid 39577830)
19. Cole A. R., Causeret F., Yadirgi G. et al. (2006) Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3 in vivo. J. Biol. Chem. 281, 16591-16598.
20. Cole A. R., Noble W., van Aalten L. et al. (2007) Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J. Neurochem. 103, 1132-1144. (Pubitemid 47568734)
21. Connor J. R. and Menzies S. L. (1995) Cellular management of iron in the brain. J. Neurol. Sci. 134(Suppl.), 33-44.
22. Dada L. A., Novoa E., Lecuona E., Sun H. and Sznajder J. I. (2007) Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells. J. Cell Sci. 120, 2214-2222. (Pubitemid 47074125)
23. Davies S. P., Reddy H., Caivano M. and Cohen P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
24. Dawson J., Hotchin N., Lax S. and Rumsby M. (2003a) Lysophosphatidic acid induces process retraction in CG-4 line oligodendrocytes and oligodendrocyte precursor cells but not in differentiated oligodendrocytes. J. Neurochem. 87, 947-957. (Pubitemid 37444570)
25. Dawson M. R., Polito A., Levine J. M. and Reynolds R. (2003b) NG2- expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 24, 476-488. (Pubitemid 37311310)
26. Desai M. K., Sudol K. L., Janelsins M. C., Mastrangelo M.A., Frazer M. E. and Bowers W. J. (2009) Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. Glia 57, 54-65.
27. Di Domenico F., Sultana R., Barone E., Perluigi M., Cini C., Mancuso C., Cai J., Pierce W. M. and Butterfield D. A. (2011) Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects. J. Proteomics 74, 1091-1103.
28. Fragoso G., Martinez-Bermudez A. K., Liu H. N., Khorchid A., Chemtob S., Mushynski W. E. and Almazan G. (2004) Developmental differences in HO-induced oligodendrocyte cell death: role of glutathione, mitogen-activated protein kinases and caspase 3. J. Neurochem. 90, 392-404. (Pubitemid 38938225)
29. Fukata Y., Itoh T. J., Kimura T. et al. (2002) CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591.
30. Gu Y. and Ihara Y. (2000) Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J. Biol. Chem. 275, 17917-17920. (Pubitemid 30414732)
31. Gu Y., Hamajima N. and Ihara Y. (2000) Neurofibrillary tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, and Ser-522. Biochemistry 39, 4267-4275. (Pubitemid 30212642)
32. Haider L., Fischer M. T., Frischer J. M. et al. (2011) Oxidative damage in multiple sclerosis lesions. Brain 134, 1914-1924.
33. Heo J. and Campbell S. L. (2005) Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J. Biol. Chem. 280, 31003-31010. (Pubitemid 41291833)
34. Hollensworth S. B., Shen C., Sim J. E., Spitz D. R., Wilson G. L. and LeDoux S. P. (2000) Glial cell type-specific responses to menadione-induced oxidative stress. Free Radic. Biol. Med. 28, 1161-1174. (Pubitemid 30417458)
35. Hou S. T., Jiang S. X., Aylsworth A., Ferguson G., Slinn J., Hu H., Leung T., Kappler J. and Kaibuchi K. (2009) CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J. Neurochem. 111, 870-881.
36. Jaillard C., Harrison S., Stankoff B. et al. (2005) Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci. 25, 1459-1469. (Pubitemid 40250722)
37. Jakovcevski I., Mo Z. and Zecevic N. (2007) Down-regulation of the axonal polysialic acid-neural cell adhesion molecule expression coincides with the onset of myelination in the human fetal forebrain. Neuroscience 149, 328-337. (Pubitemid 47576541)
38. Jana A. and Pahan K. (2007) Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. J. Neuroimmune Pharmacol. 2, 184-193.
39. Jin L., Ying Z. and Webb R. C. (2004) Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 287, H1495-1500. (Pubitemid 39313251)
40. Juurlink B. H., Thorburne S. K. and Hertz L. (1998) Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22, 371-378. (Pubitemid 28129714)
41. Kilkenny C., Browne W. J., Cuthill I. C., Emerson M. and Altman D. G. (2010) Improving bioscience research reporting: The ARRIVE Guidelines for Reporting Animal Research. PLoS Biol. 8, e1000412.
42. Lee J. T., Xu J., Lee J. M., Ku G., Han X., Yang D. I., Chen S. and Hsu C. Y. (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123-131. (Pubitemid 38082463)
43. Lee J., Gravel M., Zhang R., Thibault P. and Braun P. E. (2005) Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J. Cell Biol. 170, 661-673. (Pubitemid 41186940)
44. Liot G., Bossy B., Lubitz S., Kushnareva Y., Sejbuk N. and Bossy- Wetzel E. (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway. Cell Death Differ. 16, 899-909.
45. Majava V., Loytynoja N., Chen W. Q., Lubec G. and Kursula P. (2008) Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2. FEBS J. 275, 4583-4596.
46. McCarthy K. D. and de Vellis J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890-902. (Pubitemid 10007455)
47. Menon K. N., Steer D. L., Short M., Petratos S., Smith I. and Bernard C. C. (2011) A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Mol. Cell. Proteomics 10, M110-000042.
48. Morinaka A., Yamada M., Itofusa R. et al. (2011) Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone collapse. Sci. Signal. 4, ra26.
49. Morrison B. M., Hof P. R. and Morrison J. H. (1998) Determinants of neuronal vulnerability in neurodegenerative diseases. Ann. Neurol. 44, S32-S44. (Pubitemid 28423826)
50. Mronga T., Stahnke T., Goldbaum O. and Richter-Landsberg C. (2004) Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia 46, 446-455. (Pubitemid 38679202)
51. Nichols R. J., Dzamko N., Hutti J. E., Cantley L. C., Deak M., Moran J., Bamborough P., Reith A. D. and Alessi D. R. (2009) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem. J. 424, 47-60.
52. Novgorodov A. S., El-Alwani M., Bielawski J., Obeid L. M. and Gudz T. I. (2007) Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J. 21, 1503-1514. (Pubitemid 46684852)
53. Okada A., Tominaga M., Horiuchi M. and Tomooka Y. (2007) Plexin- A4 is expressed in oligodendrocyte precursor cells and acts as a mediator of semaphorin signals. Biochem. Biophys. Res. Commun. 352, 158-163. (Pubitemid 44821108)
54. Patrakitkomjorn S., Kobayashi D., Morikawa T. et al. (2008) Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. J. Biol. Chem. 283, 9399-9413.
55. Perez-Campo R., Lopez-Torres M., Cadenas S., Rojas C. and Barja G. (1998) The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J. Comp. Physiol. B. 168, 149-158. (Pubitemid 28202995)
56. Petratos S., Li Q. X., George A. J. et al. (2008) The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 131, 90-108.
57. Rajasekharan S., Baker K. A., Horn K. E., Jarjour A. A., Antel J. P. and Kennedy T. E. (2009) Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 136, 415-426.
58. Rajasekharan S., Bin J. M., Antel J. P. and Kennedy T. E. (2010) A central role for RhoA during oligodendroglial maturation in the switch from netrin-1-mediated chemorepulsion to process elaboration. J. Neurochem. 113, 1589-1597.
59. Ricard D., Rogemond V., Charrier E., Aguera M., Bagnard D., Belin M. F., Thomasset N. and Honnorat J. (2001) Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/ CRMP2 in Sema3a- sensitive oligodendrocytes. J. Neurosci. 21, 7203-7214. (Pubitemid 32846968)
60. Richter-Landsberg C. and Heinrich M. (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45, 161-173. (Pubitemid 26257317)
61. Richter-Landsberg C. and Vollgraf U. (1998) Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp. Cell Res. 244, 218-229. (Pubitemid 28480869)
62. Roher A. E., Weiss N., Kokjohn T. A. et al. (2002) Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41, 11080-11090. (Pubitemid 35034009)
63. Roher A. E., Kuo Y. M., Esh C. et al. (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol. Med. 9, 112-122. (Pubitemid 36819967)
64. Ryu H., Lee J., Impey S., Ratan R. R. and Ferrante R. J. (2005) Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proc. Natl Acad. Sci. USA 102, 13915-13920. (Pubitemid 41377678)
65. Sastre J., Pallardo F. V., Garcia de la Asuncion J. and Vina J. (2000) Mitochondria, oxidative stress and aging. Free Radic. Res. 32, 189-198. (Pubitemid 30140162)
66. Sholl D. A. (1953) Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 87, 387-406.
67. Sjobeck M. and Englund E. (2003) Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathol. Appl. Neurobiol. 29, 159-169. (Pubitemid 36408333)
68. Sloane J. A. and Vartanian T. K. (2007) Myosin Va controls oligodendrocyte morphogenesis and myelination. J. Neurosci. 27, 11366-11375. (Pubitemid 47621305)
69. Smith K. J., Kapoor R. and Felts P. A. (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9, 69-92. (Pubitemid 29056521)
70. Spassky N., de Castro F., Le Bras B., Heydon K., Queraud-LeSaux F., Bloch-Gallego E., Chedotal A., Zalc B. and Thomas J. L. (2002) Directional guidance of oligodendroglial migration by class 3 semaphorins and netrin-1. J. Neurosci. 22, 5992-6004. (Pubitemid 35387643)
71. Stenmark P., Ogg D., Flodin S., Flores A., Kotenyova T., Nyman T., Nordlund P. and Kursula P. (2007) The structure of human collapsin response mediator protein 2, a regulator of axonal growth. J. Neurochem. 101, 906-917. (Pubitemid 46683861)
72. Szolnoki Z. (2007) Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). NeuroMol. Med. 9, 21-33.
73. Takashima S., Itoh M. and Oka A. (2009) A history of our understanding of cerebral vascular development and pathogenesis of perinatal brain damage over the past 30 years. Semin. Pediatr. Neurol. 16, 226-236.
74. Takata K., Kitamura Y., Nakata Y., Matsuoka Y., Tomimoto H., Taniguchi T. and Shimohama S. (2009) Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease. Am. J. Pathol. 175, 17-24.
75. Uchida Y., Ohshima T., Sasaki Y. et al. (2005) Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10, 165-179. (Pubitemid 40287519)
76. Uchida Y., Ohshima T., Yamashita N., Ogawara M., Sasaki Y., Nakamura F. and Goshima Y. (2009) Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32. J. Biol. Chem. 284, 27393-27401.
77. Ulfig N., Nickel J. and Saretzki U. (1998) Alterations in myelin formation in fetal brains of twins. Pediatr. Neurol. 19, 287-293. (Pubitemid 28514116)
78. Varrin-Doyer M., Vincent P., Cavagna S., Auvergnon N., Noraz N., Rogemond V., Honnorat J., Moradi-Ameli M. and Giraudon P. (2009) Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J. Biol. Chem. 284, 13265-13276.
79. Wang L. H. and Strittmatter S. M. (1997) Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J. Neurochem. 69, 2261-2269.
80. Wang H., Tewari A., Einheber S., Salzer J. L. and Melendez-Vasquez C. V. (2008) Myosin II has distinct functions in PNS and CNS myelin sheath formation. J. Cell Biol. 182, 1171-1184.
81. Wu T. L. (2006) Two-dimensional difference gel electrophoresis. Methods Mol. Biol. 328, 71-95.
82. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A. and Kaibuchi K. (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149. (Pubitemid 40094609)
83. Younes-Rapozo V., Felgueiras L. O., Viana N. L., Fierro I. M., Barja- Fidalgo C., Manhaes A. C. and Barradas P. C. (2009) A role for the MAPK/ERK pathway in oligodendroglial differentiation in vitro: stage specific effects on cell branching. Int. J. Dev. Neurosci. 27, 757-768.